PharmaBoardroom

Chinese Sinovac Testing COVID-19 Vaccine in Brazil

In the race to develop the world’s first COVID-19 vaccine, Brazil – now one of the world’s worst-affected countries – is…

LFB USA CEO Optimistic on Hemophilia Launches Amid COVID Crisis

French firm LFB is targeting the lucrative US market with its hemophilia products and recently received two FDA approvals. Although launching new…

Jeong-Sun Seo – Chairman, Macrogen & President, KoreaBIO

Dr Jeong-Sun Seo, chairman of Macrogen & president of the Korea Biotechnology Industry Organization (KoreaBIO), explains the basis for Korea’s…

Alexander Alonso – General Manager, BD Benelux

Alexander Alonso, general manager of medtech giant BD’s operations in Belgium, the Netherlands, and Luxembourg outlines the company’s extensive…

Six Indian Companies at the Forefront of COVID-19 Vaccine…

Six Indian pharma and biotech firms have joined the global race to develop a vaccine for COVID-19 with India-developed vaccine candidates moving…

Sangrae Cho – CEO, Gencurix

Gencurix was the first Asian company to develop a prognostic diagnostic test for breast cancer. Its CEO, Dr Sangrae Cho, discusses the importance of…

Philippe de Pougnadoresse – Country President &…

Philippe de Pougnadoresse, country president & general manager pharma for Novartis Belgium & Luxembourg, outlines his affiliate’s fast and…

The Wellcome Trust’s Jeremy Farrar Speaks Out Against…

Jeremy Farrar, director of the Wellcome Trust, spoke to Financial Times correspondent Vanessa Kortekaas on 25 June 2020 about the global race to…

Vincent Stephenne – Managing Director, BePharBel…

Vincent Stephenne, managing director of Belgian CDMO BePharBel Manufacturing, highlights the company’s innovative approach to developing new galenic…

Christophe Van Damme – Vice President & General…

Christophe Van Damme, vice president and general manager of Perrigo Belgium and Luxembourg, shines a light on the transformation for Perrigo since its…

Sanofi Makes USD 679 Million Investment in French Vaccine…

French pharma giant Sanofi is pivoting its focus to invest more heavily in vaccines with a plan to invest USD 679 million in vaccine manufacturing…

Accumulating Barriers to Care: Double Jeopardy for US Patients

Dan Leonard, Kimberly Westrich, and Brian Sils of the National Pharmaceutical Council examine how a new HHS ruling on how US patients pay for…

Sign in

Tagged with